Yu zhu Wan

Dr. Yu zhu Wan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
LFLi Fang
Li Fang
CLChun-Hao Li
Chun-Hao Li
QZQian Zhang
Qian Zhang
TJTian-Jiao Jiang
Tian-Jiao Jiang
YLYuan Liu
Yuan Liu
LSLi Shi
Li Shi
Background: Mounting research indicates that brain-derived neurotrophic factor (BDNF), has great potential to increase neuro-hyperresponsiveness and airway resistance in airway allergic disease. The expression level of BDNF has been found to be notably elevated in lung/nasal lavage (NAL) fluid. However, the expression and position of BDNF in ciliated cells with allergic rhinitis remains unclear. Methods: Nasal mucosal cells were collected from patients with allergic rhinitis (AR) and mice which were performed under different allergen challenge time, then observed the expression and position of BDNF located in ciliated cells through the immunofluorescence staining. Nasal mucosa, serum and NAL fluid were collected also. The expression level of BDNF and IL-4/5/13 were detected by RT-PCR. The expressions of BDNF (in serum and NAL fluid), and total-IgE, ovalbumin sIgE (in serum) were detected by ELISA. Results: We found that MFI of BDNF in AR group’s ciliated cells was obviously lower than that in the control group, and a negative correlation was discovered between MFI and VAS score. It can be roughly divided into 5 patterns according to its location in the cytoplasm of ciliated cells. In the mouse model, the expressions of BDNF in serum and NAL fluid increased temporarily after allergen stimulation. The MFI of BDNF in ciliated cells displayed an initial increase followed by a subsequent decrease. Conclusion: Our study shows for the first time that, the expression and localization of BNDF were observed in the human nasal ciliated epithelial cells of allergic rhinitis, and the expression of level was less than the control group under the persistent state of allergy. BDNF expression in ciliated cells was transient increased after allergen stimulation and decreased to normal level after 24h in mouse model of allergic rhinitis. This might be the possible source of the transient increase of BNDF in serum and NAL fluid.

8 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SSShuJuan Sun
ShuJuan Sun
ACAiPing Chen
AiPing Chen
LSLi Shi
Li Shi
YWYu zhu Wan
Yu zhu Wan
This study aimed to evaluate the efficacies of endoscopic vidian neurectomy (VN) and highly selective vidian neurectomy (HSVN) for the treatment of allergic rhinitis (AR) and vasomotor rhinitis (VMR). All AR and VMR patients were divided into two groups, Group VN and Group HSVN. The efficacy evaluation methods were visual analog scale (VAS), rhinoconjunctivitis quality of life questionnaire (RQLQ), and medication score. The efficacy evaluations were used to assess patient rhinitis symptoms, quality of life and drug usage. The time points of follow-up period were preoperative, 3 months, 6 months, 1 year, 2 years, and 3 years post operation. By analyzing pre- and postoperative VAS, medication score and RQLQ score, the results showed that rhinitis symptoms and quality of life in both VN and HSVN groups were significantly improved at 3 years, and the rate of improvement decreased gradually with time. Post operation, there were no significant differences in VAS and medication scores between the VN and HSVN groups. With respect to RQLQ, postoperative 2 years and 3 years improvements in sleep disorders, non-nasal symptoms and eye symptoms were significantly greater in the HSVN group than in the VN group. Improvements in rhinitis symptoms and quality of life in AR and VMR were sustained by VN and HSVN until 3 years post operation, with greater quality of life improvements in the HSVN group.

2 November 2023 in The Laryngoscope
Verified
Journal Article
Closed access
YTYanyi Tu
Yanyi Tu
TJTianjiao Jiang
Tianjiao Jiang
YWYisha Wu
Yisha Wu
JLJinfeng Luo
Jinfeng Luo
SSShujuan Sun
Shujuan Sun
LSLi Shi
Li Shi

1 January 2025 in Mediators of Inflammation
Verified
Journal Article
Open access
PLPing Li
Ping Li
TLTao Li
Tao Li
JLJinfeng Luo
Jinfeng Luo
PYPeng Yu
Peng Yu
TJTao Jiang
Tao Jiang
LSLi Shi
Li Shi
Background: One of the hallmarks of Chronic rhinosinusitis with nasal polyps (CRSwNP) is the overexpression of IL‐13, which may influence the proliferation and differentiation of nasal epithelial basal cells. However, the pathway is not clear enough, and the mTOR/p70S6K1 pathway is related to cell growth. This study was trying to explore if IL‐13 could impact nasal epithelial basal cells through the mTOR/p70S6K1 pathway. Methods: PCR, western blot (WB), and immunohistochemistry (IHC) were used to compare the difference between IL‐13 and the mTOR/p70S6K1 pathway‐related molecules expression level between the healthy control (HC) and CRSwNP groups. WB, 5‐ethynyl‐2 ′ ‐deoxyuridine staining, and Immunofluorescent (IF) were performed on human nasal epithelial progenitor cells (HNEPCs) to detect the proliferation ability under the effect of IL‐13. In addition, qRT‐PCR, WB, and IF were used to detect the differentiation ability with the stimulation of IL‐13 in the air‐liquid interface (ALI) system. Results: The expression of IL‐13, mTOR/p70S6K1‐related molecules, and proliferation‐related molecules Ki67, CDK2, and cyclin E1 were upregulated in CRSwNP compared to HC. In HNEPCs, IL‐13 could stimulate nasal epithelial cells proliferating through the mTOR/p70S6K1 pathway, and this phenomenon could be inhibited when mTOR (with rapamycin) and S6K1 (with PF‐4708671) were blocked. In the ALI system, the effect of IL‐13 added in the proliferation phase could persist in the proliferation and differentiation stage, affecting the nasal epithelial progenitor/stem cells’ irregular differentiation. Conclusion: IL‐13 may affect the proliferation and differentiation of nasal epithelial progenitor/stem cells through the mTOR/p70S6K1 pathway, which may affect the development of nasal polyps.

13 March 2024 in International Journal of Audiology
Verified
Journal Article
Open access
LMLinghui Meng
Linghui Meng
DHDingqian Hao
Dingqian Hao
DLDan Li
Dan Li
JYJing Yue
Jing Yue
YWYu zhu Wan
Yu zhu Wan
LSLi Shi
Li Shi
Hearing impairment has gained widespread recognition as a major public health issue globally. By 2021, it is anticipated that over 5% of the global population will necessitate rehabilitation to tre...

6 February 2024 in Heliyon
Verified
Journal Article
Open access
YWYisha Wu
Yisha Wu
DHDingqian Hao
Dingqian Hao
YTYanyi Tu
Yanyi Tu
LCLin Chen
Lin Chen
PYPeng Yu
Peng Yu
LSLi Shi
Li Shi
Antrochoanal polyp (ACP) is a benign nasal mass of unknown etiology. Tight junctions (TJs) are essential to the epithelial barrier that protects the body from external damage. However, the phenotype of tight junction in ACP is currently unclear. The samples were collected from 20 controls, 37 patients with ACP and 45 patients with chronic rhinosinusitis with nasal polyp (CRSwNP). Quantitative Real-Time PCR (qRT-PCR) and immunofluorescence staining (IF) were performed to analyze the expressions of TJs markers (ZO-1, claudin-3 and occludin) and ZEB1. hNEpCs were transfected with ZEB1 small interfering RNA (si-ZEB1) or ZEB1 over-expression plasmid (OE-ZEB1). qRT-PCR and Western blotting were used to determine the levels of TJs-related markers. Primary human nasal epithelial cells (hNECs) were stimulated with IL-17A and si-ZEB1, and the expression of epithelial barrier markers were measured by qRT-PCR and Western blotting. Compared to the control group, ACP group showed a significant downregulation in both mRNA and protein levels of ZO-1, occludin, and claudin-3. Furthermore, disease severity correlates positively with the degree of disruption of tight junctions. In addition, higher expression levels of ZEB1, IL-17A, and IFN-γ were observed in the ACP group compared to controls. Overexpression of ZEB1 in hNEpCs led to impairments in the levels of ZO-1, occludin, and claudin-3, while silencing of ZEB1 expression was found to enhance the barrier function of epithelial cells. Finally, IL-17 stimulation of hNECs impaired the expression of TJs-associated molecules (ZO-1, occludin, and claudin-3), which was effectively reversed by the IL-17A + si-ZEB1 group. The tight junctions in ACP were extremely damaged and were correlated with the severity of the disease. ZEB1 was involved in the pathogenesis of ACP mediated by IL-17A through regulating tight junctions.